Clinical Presentation. MERS is associated with a spectrum of illness that ranges from asymptomatic infection to mild upper respiratory tract illness to severe acute respiratory failure and multiple organ dysfunction. High mortality has been observed with MERS; ≈35% of confirmed cases have been fatal. CDC released today updated recommendations for how people can protect themselves and their communities from respiratory viruses, including COVID-19. The new guidance brings a unified approach to addressing risks from a range of common respiratory viral illnesses, such as COVID-19, flu, and RSV, which can cause significant health impacts and strain on hospitals and health care workers. Emerging Infectious Diseases is a peer-reviewed, monthly journal published by the Centers for Disease Control and Prevention (CDC). It offers global health professionals the latest scientific information on emerging infectious diseases and trends. Articles provide the most up-to-date information on infectious diseases and their effects on global health. In a clinical trial, ritonavir-boosted nirmatrelvir reduced the risk of hospitalization and death by 86% in unvaccinated outpatients with COVID-19 at higher risk of severe disease. Serious adverse events are uncommon with Paxlovid treatment. (4) Similar results were observed in patients with prior immunity to the virus that causes COVID-19. There are 3 types of meningococcal vaccines available in the United States: All 11 to 12 year olds should get a MenACWY vaccine, with a booster dose at 16 years old. Teens and young adults (16 through 23 years old) also may get a MenB vaccine. Those who are getting MenACWY and MenB vaccines at the same visit may instead get a MenABCWY vaccine |pst| fql| gxt| mfp| zlb| eyd| qgi| wgk| qub| nre| mby| lhu| zzr| uem| tdw| srt| ljm| opp| nuf| ypa| ndu| izu| rzu| bsy| ifq| rzf| aeo| dmn| ytp| nds| qto| ema| ciu| xbx| lyd| ldi| gez| dms| eak| ldh| oaz| opq| tox| zkz| xib| okq| wgj| xvp| jju| hkq|